Example: Heart Attack

Search clinical trials for: Bleomycin

Total 141 results

NCT01042522

Active, not recruiting

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

Conditions: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor, Ovarian Sex Cord Tumor With Annular Tubules, Ovarian Sex Cord-Stromal Tumor, Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified, Ovarian Steroid Cell Tumor
NCT03407144

Recruiting

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Conditions: Hodgkin Lymphoma
NCT03067181

Recruiting

Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Conditions: Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor, Malignant Germ Cell Tumor, Malignant Ovarian Teratoma, Stage I Ovarian Choriocarcinoma, Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage I Ovarian Teratoma AJCC v6 and v7, Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7, Stage I Testicular Choriocarcinoma AJCC v6 and v7, Stage I Testicular Embryonal Carcinoma AJCC v6 and v7, Stage I Testicular Seminoma AJCC v6 and v7, Stage I Testicular Yolk Sac Tumor AJCC v6 and v7, Stage II Ovarian Choriocarcinoma, Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7, Stage II Testicular Choriocarcinoma AJCC v6 and v7, Stage II Testicular Embryonal Carcinoma AJCC v6 and v7, Stage II Testicular Yolk Sac Tumor AJCC v6 and v7, Stage III Ovarian Choriocarcinoma, Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7, Stage III Testicular Choriocarcinoma AJCC v6 and v7, Stage III Testicular Embryonal Carcinoma AJCC v6 and v7, Stage III Testicular Yolk Sac Tumor AJCC v6 and v7, Stage IV Ovarian Choriocarcinoma, Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7, Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7, Testicular Mixed Choriocarcinoma and Embryonal Carcinoma, Testicular Mixed Choriocarcinoma and Teratoma, Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
NCT02661503

Recruiting

HD21 for Advanced Stages

Conditions: Classical Hodgkin Lymphoma
NCT01132807

Completed

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Conditions: Lymphoma
NCT03159897

Active, not recruiting

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Conditions: Hodgkin Lymphoma
NCT02166463

Active, not recruiting

Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma

Conditions: Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IV Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma, Ann Arbor Stage IVB Hodgkin Lymphoma, Childhood Hodgkin Lymphoma, Classic Hodgkin Lymphoma
NCT00104676

Active, not recruiting

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

Conditions: Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor
NCT02298283

Completed

Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD

Conditions: Hodgkin Lymphoma
NCT00678327

Active, not recruiting

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Conditions: Lymphoma
NCT02352259

Completed

Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

Conditions: Liver Metastases
NCT03755804

Recruiting

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Conditions: Hodgkin Lymphoma
NCT04281290

Terminated

Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)

Conditions: Pancreas Cancer
NCT00352027

Active, not recruiting

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

Conditions: Hodgkin's Lymphoma
NCT00822120

Active, not recruiting

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Conditions: Lymphoma, Nonneoplastic Condition
NCT04760327

Recruiting

Electrochemotherapy of Gynecological Cancers

Conditions: Gynecological Cancers
NCT00049595

Active, not recruiting

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Conditions: Lymphoma
NCT02104986

Active, not recruiting

A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent

Conditions: Extra Cranial Non Seminomateous Malignant Germ Cell Tumour
NCT00379041

Active, not recruiting

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00005584

Active, not recruiting

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00002462

Active, not recruiting

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Conditions: Lymphoma
NCT03199300

Recruiting

Investigating Cardiovascular Adverse Events Related to Cancer Treatment

Conditions: Toxicity Due to Chemotherapy, Cardiovascular Morbidity, Cancer, Treatment-Related
NCT04685616

Not yet recruiting

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Conditions: Hodgkin Lymphoma
NCT01712490

Active, not recruiting

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Conditions: Hodgkin Lymphoma
NCT01390584

Terminated

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Conditions: Lymphoma